← Eichor
Study identifier: NCT07128472 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of IL 12B Genetic Polymorphism (rs3213094)

Condition: Psoriasis  ·  Sponsor: South Valley University

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersYes

About this study

Psoriasis is a skin disorder that is chronic proliferative and inflammatory in nature. Extensor surfaces, scalp, and lumbosacral area are covered in erythematous plaques with silvery scales. The disease can also impair the eyes and joints. It has no cure. Because of their low quality of life, many psoriasis patients experience depression. In addition to the cutaneous manifestations, it is associated with an increased risk of psoriatic arthritis, depression and cardiovascular disease.

This description comes directly from the study's public registry record.

Talk to the study team

Alaa Ahmed Saad Ali Aweida, MSc  ·  +201119814470  ·  alaaahmed201666@gmail.com

Soheir Abdel-Hamid Ali, Lecturer  ·  +201066877343  ·  Soher.abdel-hamed@med.svu.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Qina University hospital, South Valley University HospitalQina, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07128472